Rebecca Jones
Research Subjects
Research Interests
Rebecca Jones has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Shawn Kepner
Patient Safety Authority
8 shared publications - Christine E. Sanchez
Patient Safety Authority
4 shared publications - Myungsun Ro
Patient Safety Authority
4 shared publications Ella S. Franklin
MedStar Health National Center for Human Factors in Healthcare
3 shared publications- Jessica L. Handley
MedStar Health National Center for Human Factors in Healthcare
3 shared publications - Katharine T. Adams
MedStar Center for Biostatistics, Informatics, and Data Science
3 shared publications
Latest Publications
- Open Access
- 7 August 2026
- Published by Patient Safety Authority in Patient Safety
- Vol. 8 (2)
Inpatient Use of Continuous Glucose Monitors: Insights From Pennsylvania Patient Safety Event Reports
Introduction: Inpatient use of continuous glucose monitors (CGMs) has historically been prohibited. Increased outpatient use, critical needs during the COVID-19 pandemic, and growing interest in allowing use of CGMs to manage blood glucose levels for hospitalized patients have prompted consideration of allowing inpatient use of these devices to manage blood glucose levels. Methods: We conducted a retrospective mixed-methods study using event reports submitted to the Pennsylvania Patient Safety Reporting System (PA-PSRS) from 2022 to 2025 to identify inpatient safety events in which the presence or use of a CGM could have influenced the risk of patient harm. Structured and narrative data were coded and analyzed to characterize variables related to CGM use and assess the potential impact of CGMs on patient safety. Results: We identified and analyzed 165 reports from 51 hospitals. More than 70% of reports described events in which the presence or use of a CGM increased the risk of patient harm (CGM risk events), while the remaining reports described a reduced risk (CGM mitigation events). Among CGM risk events, the most frequent issues were off-policy blood glucose monitoring (23.9%), missing CGM-related documentation (17.1%), malfunctioned and/or expired CGM (15.4%), unauthorized insulin administration (13.7%), and failure to remove or cover CGM (9.4%). Patients’ desire to use their personal CGM appeared across several CGM risk events, whereas transparent communication of glycemic information between patients and providers was commonly described in CGM mitigation events. Conclusion: Data from this study showed that inpatient CGM use was associated with both increased and reduced risk of patient harm. Clear policies and consistent patient-provider communication may help to minimize these risks and enhance patient benefit. Plain Language Summary: Many people with Type 1 or Type 2 diabetes use continuous glucose monitors (CGMs). These small wearable devices help track blood sugar levels throughout the day. Even though people commonly use continuous glucose monitors at home, hospitals have been slower to allow their use. This is due to uncertainty concerning their safety and accuracy in a clinical setting, versus the standard procedure of finger-stick blood testing several times a day. However, recent research, and the Food and Drug Administration’s temporary approval of in-hospital CGM use during the height of the COVID-19 pandemic, suggest that when used correctly, CGMs can be a reliable alternative to finger-stick tests, as well as offer additional benefits in monitoring and maintaining glucose levels of inpatients. A recent review by Patient Safety Authority research scientists discovered that inpatient CGM use can be associated with both an increased and decreased risk of harm. Researchers found that when CGMs increased risk of harm, issues such as off-policy blood glucose monitoring, missing documentation, and unauthorized insulin administration occurred. However, the data representing a decreased risk of harm associated with CGM use highlights the potential for CGMs to be useful tools during a hospital stay. As CGM usage increases due to patient preferences and shifting hospital policies, facilities should consider the strategies outlined in this article and establish clear, consistent procedures and collaborative communication between patients and providers to foster safe, effective CGM use.
- 7 August 2026
- Published by Patient Safety Authority in Patient Safety
- Vol. 8 (2)
Open AccessInpatient Use of Continuous Glucose Monitors: Insights From Pennsylvania Patient Safety Event Reports
Introduction: Inpatient use of continuous glucose monitors (CGMs) has historically been prohibited. Increased outpatient use, critical needs during the COVID-19 pandemic, and growing interest in allowing use of CGMs to manage blood glucose levels for hospitalized patients have prompted consideration of allowing inpatient use of these devices to manage blood glucose levels. Methods: We conducted a retrospective mixed-methods study using event reports submitted to the Pennsylvania Patient Safety Reporting System (PA-PSRS) from 2022 to 2025 to identify inpatient safety events in which the presence or use of a CGM could have influenced the risk of patient harm. Structured and narrative data were coded and analyzed to characterize variables related to CGM use and assess the potential impact of CGMs on patient safety. Results: We identified and analyzed 165 reports from 51 hospitals. More than 70% of reports described events in which the presence or use of a CGM increased the risk of patient harm (CGM risk events), while the remaining reports described a reduced risk (CGM mitigation events). Among CGM risk events, the most frequent issues were off-policy blood glucose monitoring (23.9%), missing CGM-related documentation (17.1%), malfunctioned and/or expired CGM (15.4%), unauthorized insulin administration (13.7%), and failure to remove or cover CGM (9.4%). Patients’ desire to use their personal CGM appeared across several CGM risk events, whereas transparent communication of glycemic information between patients and providers was commonly described in CGM mitigation events. Conclusion: Data from this study showed that inpatient CGM use was associated with both increased and reduced risk of patient harm. Clear policies and consistent patient-provider communication may help to minimize these risks and enhance patient benefit. Plain Language Summary: Many people with Type 1 or Type 2 diabetes use continuous glucose monitors (CGMs). These small wearable devices help track blood sugar levels throughout the day. Even though people commonly use continuous glucose monitors at home, hospitals have been slower to allow their use. This is due to uncertainty concerning their safety and accuracy in a clinical setting, versus the standard procedure of finger-stick blood testing several times a day. However, recent research, and the Food and Drug Administration’s temporary approval of in-hospital CGM use during the height of the COVID-19 pandemic, suggest that when used correctly, CGMs can be a reliable alternative to finger-stick tests, as well as offer additional benefits in monitoring and maintaining glucose levels of inpatients. A recent review by Patient Safety Authority research scientists discovered that inpatient CGM use can be associated with both an increased and decreased risk of harm. Researchers found that when CGMs increased risk of harm, issues such as off-policy blood glucose monitoring, missing documentation, and unauthorized insulin administration occurred. However, the data representing a decreased risk of harm associated with CGM use highlights the potential for CGMs to be useful tools during a hospital stay. As CGM usage increases due to patient preferences and shifting hospital policies, facilities should consider the strategies outlined in this article and establish clear, consistent procedures and collaborative communication between patients and providers to foster safe, effective CGM use.
- Open Access
- 27 April 2026
- Published by Patient Safety Authority in Patient Safety
- Vol. 8 (2)
Long-Term Care Healthcare-Associated Infections in 2025: Analysis of 30,967 Reports From Pennsylvania
Background: The Pennsylvania Patient Safety Reporting System (PA-PSRS) is the largest patient safety data repository of its kind in the United States. The PA-PSRS database contains over 5.8 million reports, including more than 473,000 long-term care (LTC) healthcare-associated infection (HAI) reports. Methods: LTC HAI data from PA-PSRS were extracted on March 1, 2026. Infection counts were calculated based on report submission date, and rates were calculated based on infection confirmation date. Reports from LTC facilities and specific care areas were included in rate calculations if resident and device days were also entered in PA-PSRS for the corresponding month. Results: In 2025, Pennsylvania’s LTC facilities submitted 30,967 infection reports to PA-PSRS, a 16.9% increase over the prior year and the fourth consecutive annual increase, with all four increases exceeding 10%. The overall infection rate was 1.25 infections per 1,000 resident days, representing a 15.7% increase from 2024. The 2025 rate also established a significant four-year increasing linear trend since the low point of 0.77 in 2021 (R 2 =0.989, p=0.0005). Infection rates increased across all regions of the state except the Northeast, which remained unchanged, with the largest increase observed in the Southeast region, where the rate rose by 0.26 points (32.9%) from 2024 to 2025. The overall infection rate increased due to rising rates across all infection types, except for device-related bloodstream infections, for which the rate remained the same. Respiratory tract infections had the largest increase in both number and percentage, driven largely by influenza, which rose by 1,652 reports (117.7%). Reports of gastrointestinal infections increased as well, attributable to an 84.7% increase in norovirus. Conclusion: In 2025, the number of infection reports submitted to PA-PSRS and the overall infection rate increased, due to a rise in all infection types except for device-related bloodstream infections. Respiratory tract infections, particularly influenza, showed the most substantial increase. Plain Language Summary: In conjunction with the Patient Safety Authority’s 2025 annual report, PSA took a close look at the 30,967 healthcare-associated infections (HAIs) reported last year by long-term care facilities (e.g., nursing homes) to the Pennsylvania Patient Safety Reporting System (PA-PSRS). The total number of infection reports was a 16.9% increase from 2024 to 2025—the fourth consecutive annual increase—and the overall infection rate (1.25 infections per 1,000 resident days) was a 15.7% increase from the previous year, attributed to rising rates across all infection types, excluding device-related bloodstream infections. Of these, there were notable increases in respiratory tract infections, primarily due to a 117.7% increase in influenza reports, and gastrointestinal infections, which included an 84.7% increase in norovirus.
- 27 April 2026
- Published by Patient Safety Authority in Patient Safety
- Vol. 8 (2)
Open AccessLong-Term Care Healthcare-Associated Infections in 2025: Analysis of 30,967 Reports From Pennsylvania
Background: The Pennsylvania Patient Safety Reporting System (PA-PSRS) is the largest patient safety data repository of its kind in the United States. The PA-PSRS database contains over 5.8 million reports, including more than 473,000 long-term care (LTC) healthcare-associated infection (HAI) reports. Methods: LTC HAI data from PA-PSRS were extracted on March 1, 2026. Infection counts were calculated based on report submission date, and rates were calculated based on infection confirmation date. Reports from LTC facilities and specific care areas were included in rate calculations if resident and device days were also entered in PA-PSRS for the corresponding month. Results: In 2025, Pennsylvania’s LTC facilities submitted 30,967 infection reports to PA-PSRS, a 16.9% increase over the prior year and the fourth consecutive annual increase, with all four increases exceeding 10%. The overall infection rate was 1.25 infections per 1,000 resident days, representing a 15.7% increase from 2024. The 2025 rate also established a significant four-year increasing linear trend since the low point of 0.77 in 2021 (R 2 =0.989, p=0.0005). Infection rates increased across all regions of the state except the Northeast, which remained unchanged, with the largest increase observed in the Southeast region, where the rate rose by 0.26 points (32.9%) from 2024 to 2025. The overall infection rate increased due to rising rates across all infection types, except for device-related bloodstream infections, for which the rate remained the same. Respiratory tract infections had the largest increase in both number and percentage, driven largely by influenza, which rose by 1,652 reports (117.7%). Reports of gastrointestinal infections increased as well, attributable to an 84.7% increase in norovirus. Conclusion: In 2025, the number of infection reports submitted to PA-PSRS and the overall infection rate increased, due to a rise in all infection types except for device-related bloodstream infections. Respiratory tract infections, particularly influenza, showed the most substantial increase. Plain Language Summary: In conjunction with the Patient Safety Authority’s 2025 annual report, PSA took a close look at the 30,967 healthcare-associated infections (HAIs) reported last year by long-term care facilities (e.g., nursing homes) to the Pennsylvania Patient Safety Reporting System (PA-PSRS). The total number of infection reports was a 16.9% increase from 2024 to 2025—the fourth consecutive annual increase—and the overall infection rate (1.25 infections per 1,000 resident days) was a 15.7% increase from the previous year, attributed to rising rates across all infection types, excluding device-related bloodstream infections. Of these, there were notable increases in respiratory tract infections, primarily due to a 117.7% increase in influenza reports, and gastrointestinal infections, which included an 84.7% increase in norovirus.
- Open Access
- 27 April 2026
- Published by Patient Safety Authority in Patient Safety
- Vol. 8 (2)
Patient Safety in Acute and Ambulatory Care in 2025: Analysis of 326,672 Event Reports From Pennsylvania
Background: The Pennsylvania Patient Safety Reporting System (PA-PSRS) is the largest patient safety data repository of its kind in the United States and one of the largest globally, encompassing more than 5.8 million reports. Of these, over 5.3 million are housed in the acute care database, comprising reports submitted by acute and ambulatory healthcare facilities. In this article, we present data from reports submitted to the PA-PSRS acute care database in 2025, along with select data from prior years for comparison. Methods: We used data extracted from PA-PSRS and obtained from the Pennsylvania Health Care Cost Containment Council (PHC4). Report counts are based on the date the report was submitted, while reporting rates are calculated using the event occurrence date. Rates are expressed per 1,000 patient days for hospitals or 1,000 surgical encounters for ambulatory surgical facilities (ASFs). Results: In 2025, 326,672 reports were submitted to PA-PSRS, a 3.6% increase from 2024. Reports of serious events rose by 2.4%, while high harm events, a subset of serious events, decreased by 5.8%. Of all reports, 96.4% originated from hospitals and 3.6% from nonhospital facilities (ASFs, birthing centers, and abortion facilities). Incidents accounted for 96.0% of reports, and 4.0% were classified as serious events. Preliminary 2025 reporting rates show 32.0 reports per 1,000 patient days for hospitals and 10.9 reports per 1,000 surgical encounters for ASFs, with both rates decreasing by 0.5 points from 2024. Error Related to Procedure/Treatment/Test (P/T/T) remained the most frequently reported event type overall, representing 32.1% of all reports and 43.6% of reports from nonhospital facilities. Among serious events, Complication of P/T/T was the most common type, accounting for 55.4% of serious events overall and 72.5% from nonhospital facilities. Conclusion: In 2025, total reports and serious event reports increased, while high harm reports decreased. Preliminary reporting rates for hospitals and ASFs decreased by 0.5 points from 2024. Apparent year-to-year changes may arise from reporting variation rather than broader shifts, underscoring the need to account for facility-level context and data quality limitations when interpreting statewide patient safety data. The Patient Safety Authority will continue working with Pennsylvania healthcare facilities to enhance reporting quality and promote patient safety. Plain Language Summary: In conjunction with the Patient Safety Authority’s 2025 annual report, PSA took a close look at the 326,672 incidents and serious events reported last year by hospitals, ambulatory surgical facilities (ASFs), birthing centers, and abortion facilities to the Pennsylvania Patient Safety Reporting System (PA-PSRS). The total number of reports increased 3.6% from 2024 to 2025, while preliminary reporting rates for hospitals (32.0 reports per 1,000 patient days) and ASFs (10.9 reports per 1,000 surgical encounters) decreased by 0.5 points from 2024. This comprehensive review and analysis of 2025 PA-PSRS reports may indicate that year-to-year changes can be attributed to variations in reporting rather than broader shifts. PSA will continue to work with Pennsylvania healthcare facilities to enhance the quality of event reporting.
- 27 April 2026
- Published by Patient Safety Authority in Patient Safety
- Vol. 8 (2)
Open AccessPatient Safety in Acute and Ambulatory Care in 2025: Analysis of 326,672 Event Reports From Pennsylvania
Background: The Pennsylvania Patient Safety Reporting System (PA-PSRS) is the largest patient safety data repository of its kind in the United States and one of the largest globally, encompassing more than 5.8 million reports. Of these, over 5.3 million are housed in the acute care database, comprising reports submitted by acute and ambulatory healthcare facilities. In this article, we present data from reports submitted to the PA-PSRS acute care database in 2025, along with select data from prior years for comparison. Methods: We used data extracted from PA-PSRS and obtained from the Pennsylvania Health Care Cost Containment Council (PHC4). Report counts are based on the date the report was submitted, while reporting rates are calculated using the event occurrence date. Rates are expressed per 1,000 patient days for hospitals or 1,000 surgical encounters for ambulatory surgical facilities (ASFs). Results: In 2025, 326,672 reports were submitted to PA-PSRS, a 3.6% increase from 2024. Reports of serious events rose by 2.4%, while high harm events, a subset of serious events, decreased by 5.8%. Of all reports, 96.4% originated from hospitals and 3.6% from nonhospital facilities (ASFs, birthing centers, and abortion facilities). Incidents accounted for 96.0% of reports, and 4.0% were classified as serious events. Preliminary 2025 reporting rates show 32.0 reports per 1,000 patient days for hospitals and 10.9 reports per 1,000 surgical encounters for ASFs, with both rates decreasing by 0.5 points from 2024. Error Related to Procedure/Treatment/Test (P/T/T) remained the most frequently reported event type overall, representing 32.1% of all reports and 43.6% of reports from nonhospital facilities. Among serious events, Complication of P/T/T was the most common type, accounting for 55.4% of serious events overall and 72.5% from nonhospital facilities. Conclusion: In 2025, total reports and serious event reports increased, while high harm reports decreased. Preliminary reporting rates for hospitals and ASFs decreased by 0.5 points from 2024. Apparent year-to-year changes may arise from reporting variation rather than broader shifts, underscoring the need to account for facility-level context and data quality limitations when interpreting statewide patient safety data. The Patient Safety Authority will continue working with Pennsylvania healthcare facilities to enhance reporting quality and promote patient safety. Plain Language Summary: In conjunction with the Patient Safety Authority’s 2025 annual report, PSA took a close look at the 326,672 incidents and serious events reported last year by hospitals, ambulatory surgical facilities (ASFs), birthing centers, and abortion facilities to the Pennsylvania Patient Safety Reporting System (PA-PSRS). The total number of reports increased 3.6% from 2024 to 2025, while preliminary reporting rates for hospitals (32.0 reports per 1,000 patient days) and ASFs (10.9 reports per 1,000 surgical encounters) decreased by 0.5 points from 2024. This comprehensive review and analysis of 2025 PA-PSRS reports may indicate that year-to-year changes can be attributed to variations in reporting rather than broader shifts. PSA will continue to work with Pennsylvania healthcare facilities to enhance the quality of event reporting.
- Open Access
- 30 January 2026
- Published by Patient Safety Authority in Patient Safety
- Vol. 8 (2)
Large-Scale Insulin Overdoses From Syringe-Related Errors: Analysis and Insights Across 47 Hospitals
Background: Insulin is a high-alert medication associated with numerous medication errors. We sought to analyze syringe-related issues which we defined as the use or selection of a syringe during insulin preparation, dispensing, or administration that contributed to, or had the potential to contribute to, a dosing error or discrepancy. Methods: A retrospective mixed-methods study was conducted using Medication Error event reports from the Pennsylvania Patient Safety Reporting System (PA-PSRS) from 2015 to 2024. A targeted query identified reports involving U-100 insulin and syringe-related issues resulting in dosing errors or near misses. Structured and free-text data were coded for variables such as clinical indication, route of administration, wrong dose ratio, syringe size, and contributing factors. Results: Seventy-four reports across 47 facilities met inclusion criteria. Serious events accounted for over one-third of errors that reached the patient. Tenfold overdoses were most frequent, occurring in 56.4% of reports with a wrong dose ratio, followed by hundredfold overdoses in 20.0%. Reports from the emergency department care area group had the highest frequency of tenfold overdoses, while intensive care unit reports had the greatest proportion of hundredfold overdoses. More than 97% of wrong dose errors that reached the patient resulted in an overdose of tenfold or greater. Among reports specifying syringe volume, 73.8% involved a 1-milliliter syringe; 95.2% of overdoses in these reports were exactly tenfold. Contributing factors included improper syringe storage, similar appearance, and lack of provider experience. Variability in hospital insulin protocols and formularies was also observed. Conclusion: Syringe-related issues present a serious and preventable threat to patient safety. Facilities are encouraged to evaluate their insulin protocols and adopt strategies to prevent and mitigate patient harm associated with syringe-related issues. Plain Language Summary: Although insulin is used daily by millions of people around the world, it is considered a high-alert drug that has been associated with more medication errors than any other medication type or class. One challenge in administering insulin is that it is measured in “units” rather than milliliters (mL), requiring unique insulin syringes with the appropriate markings. Using a syringe intended for other medication to administer insulin could lead to an overdose of up to 100 times the intended dose. To identify contributing factors and develop strategies to reduce the risk of wrong dose errors related to the use or selection of syringes, researchers focused on event reports submitted by Pennsylvania facilities over the last decade that involved U-100 insulin and syringe-related issues resulting in dosing errors or near misses. Some of the key takeaways of their detailed study—which encompassed 74 reports from 47 facilities—are that over a third of errors that reached the patient were serious events and among reports specifying syringe volume, 73.8% involved a 1-mL syringe. Contributing factors included using the wrong syringe due to improper syringe storage, similar cap color or packaging, and provider’s lack of experience. Variability in hospital insulin protocols and formularies was also observed. The authors encourage facilities to evaluate and standardize their existing insulin protocols and formularies, and implement the suggested safety strategies for preventing syringe-related insulin dose errors.
- 30 January 2026
- Published by Patient Safety Authority in Patient Safety
- Vol. 8 (2)
Open AccessLarge-Scale Insulin Overdoses From Syringe-Related Errors: Analysis and Insights Across 47 Hospitals
Background: Insulin is a high-alert medication associated with numerous medication errors. We sought to analyze syringe-related issues which we defined as the use or selection of a syringe during insulin preparation, dispensing, or administration that contributed to, or had the potential to contribute to, a dosing error or discrepancy. Methods: A retrospective mixed-methods study was conducted using Medication Error event reports from the Pennsylvania Patient Safety Reporting System (PA-PSRS) from 2015 to 2024. A targeted query identified reports involving U-100 insulin and syringe-related issues resulting in dosing errors or near misses. Structured and free-text data were coded for variables such as clinical indication, route of administration, wrong dose ratio, syringe size, and contributing factors. Results: Seventy-four reports across 47 facilities met inclusion criteria. Serious events accounted for over one-third of errors that reached the patient. Tenfold overdoses were most frequent, occurring in 56.4% of reports with a wrong dose ratio, followed by hundredfold overdoses in 20.0%. Reports from the emergency department care area group had the highest frequency of tenfold overdoses, while intensive care unit reports had the greatest proportion of hundredfold overdoses. More than 97% of wrong dose errors that reached the patient resulted in an overdose of tenfold or greater. Among reports specifying syringe volume, 73.8% involved a 1-milliliter syringe; 95.2% of overdoses in these reports were exactly tenfold. Contributing factors included improper syringe storage, similar appearance, and lack of provider experience. Variability in hospital insulin protocols and formularies was also observed. Conclusion: Syringe-related issues present a serious and preventable threat to patient safety. Facilities are encouraged to evaluate their insulin protocols and adopt strategies to prevent and mitigate patient harm associated with syringe-related issues. Plain Language Summary: Although insulin is used daily by millions of people around the world, it is considered a high-alert drug that has been associated with more medication errors than any other medication type or class. One challenge in administering insulin is that it is measured in “units” rather than milliliters (mL), requiring unique insulin syringes with the appropriate markings. Using a syringe intended for other medication to administer insulin could lead to an overdose of up to 100 times the intended dose. To identify contributing factors and develop strategies to reduce the risk of wrong dose errors related to the use or selection of syringes, researchers focused on event reports submitted by Pennsylvania facilities over the last decade that involved U-100 insulin and syringe-related issues resulting in dosing errors or near misses. Some of the key takeaways of their detailed study—which encompassed 74 reports from 47 facilities—are that over a third of errors that reached the patient were serious events and among reports specifying syringe volume, 73.8% involved a 1-mL syringe. Contributing factors included using the wrong syringe due to improper syringe storage, similar cap color or packaging, and provider’s lack of experience. Variability in hospital insulin protocols and formularies was also observed. The authors encourage facilities to evaluate and standardize their existing insulin protocols and formularies, and implement the suggested safety strategies for preventing syringe-related insulin dose errors.
- Open Access
- 31 December 2025
- Published by Patient Safety Authority in Patient Safety
- Vol. 7 (2)
New Research Shows Discharge Window as High-Risk Period for Patient Falls
Patient Safety Authority. She is responsible for utilizing patient safety data, combined with relevant literature, to develop strategies aimed at improving patient safety in Pennsylvania. Rebecca Jones, director of Data Science & Research for the Patient Safety Authority, leads a multidisciplinary team advancing patient safety through research that informs improvements in healthcare systems and delivers insights that bridge the gap between evidence and real-world practice. A registered nurse with a Master of Business Administration in healthcare management and certifications in patient safety, human factors, and risk management, she brings clinical experience, analytical expertise, and systems thinking to complex challenges. She has authored more than 40 peer-reviewed publications and contributed to national patient safety efforts with organizations such as the Institute for Healthcare Improvement, the National Quality Forum, and the Society to Improve Diagnosis in Medicine.
- 31 December 2025
- Published by Patient Safety Authority in Patient Safety
- Vol. 7 (2)
Open AccessNew Research Shows Discharge Window as High-Risk Period for Patient Falls
Patient Safety Authority. She is responsible for utilizing patient safety data, combined with relevant literature, to develop strategies aimed at improving patient safety in Pennsylvania. Rebecca Jones, director of Data Science & Research for the Patient Safety Authority, leads a multidisciplinary team advancing patient safety through research that informs improvements in healthcare systems and delivers insights that bridge the gap between evidence and real-world practice. A registered nurse with a Master of Business Administration in healthcare management and certifications in patient safety, human factors, and risk management, she brings clinical experience, analytical expertise, and systems thinking to complex challenges. She has authored more than 40 peer-reviewed publications and contributed to national patient safety efforts with organizations such as the Institute for Healthcare Improvement, the National Quality Forum, and the Society to Improve Diagnosis in Medicine.
- Open Access
- 18 September 2025
- Published by Walter de Gruyter GmbH in Diagnosis
- Vol. 12 (4) , 510-519
The Society to Improve Diagnosis in Medicine’s legacy: building a foundation for diagnostic excellence
The Society to Improve Diagnosis in Medicine (SIDM) played a pivotal role in elevating diagnostic error from an overlooked aspect of patient safety to a recognized healthcare priority during its thirteen-year history (2011–2024). Through strategic advocacy, coalition building, and engagement with policymakers, SIDM secured dedicated federal funding for diagnostic safety research and promoted diagnostic excellence as a critical healthcare imperative. This article examines the organization’s establishment, evolution and lasting impact on the field of diagnostic safety across research, education, practice improvement, and patient engagement. A crowning achievement was SIDM’s success in stimulating the Institute of Medicine to study the problem, resulting in the landmark 2015 report Improving Diagnosis in Health Care (1). Despite the transformative impact of this report, substantial challenges remain in reducing harm from diagnostic error. We conclude with a call to address gaps in three critical areas: awareness, measurement, and implementation.
- 18 September 2025
- Published by Walter de Gruyter GmbH in Diagnosis
- Vol. 12 (4) , 510-519
Open AccessThe Society to Improve Diagnosis in Medicine’s legacy: building a foundation for diagnostic excellence
The Society to Improve Diagnosis in Medicine (SIDM) played a pivotal role in elevating diagnostic error from an overlooked aspect of patient safety to a recognized healthcare priority during its thirteen-year history (2011–2024). Through strategic advocacy, coalition building, and engagement with policymakers, SIDM secured dedicated federal funding for diagnostic safety research and promoted diagnostic excellence as a critical healthcare imperative. This article examines the organization’s establishment, evolution and lasting impact on the field of diagnostic safety across research, education, practice improvement, and patient engagement. A crowning achievement was SIDM’s success in stimulating the Institute of Medicine to study the problem, resulting in the landmark 2015 report Improving Diagnosis in Health Care (1). Despite the transformative impact of this report, substantial challenges remain in reducing harm from diagnostic error. We conclude with a call to address gaps in three critical areas: awareness, measurement, and implementation.
- Open Access
- 18 August 2025
- Published by Patient Safety Authority in Patient Safety
- Vol. 7 (2)
The Overlooked Threat of Hospital Falls During the Discharge Period: A Statewide Retrospective Analysis of Patient Safety Event Reports
Background: Inpatient falls continue to be a patient safety challenge, with 35,450 falls reported to the Pennsylvania Patient Safety Reporting System (PA-PSRS) in 2024. While previous research has primarily focused on inpatient or post-discharge falls, the transitional period surrounding discharge has been understudied. Methods: We queried the PA-PSRS database for fall reports submitted between July 1, 2023, and June 30, 2024. Using a stepwise refinement process, we identified a subset of falls that occurred around the time of discharge for inclusion in the falls surrounding discharge group. We used a two-proportion z-test to compare the proportion of serious events between the discharge group and the broader comparison group. We further analyzed and coded reports from the falls surrounding discharge group to identify fall type, discharge phase, injury type, discharge plan outcome, and staff presence/assistance. Results: A total of 253 falls surrounding discharge were identified for analysis. The proportion of serious events in this group (7.5%; 19 of 253) was significantly greater than in the comparison group (2.9%; 749 of 25,701; pambulating was the most common (33.2%; 84 of 253). Over one-quarter of patients (28.5%; 72 of 253) were in the discharge complete phase when their fall occurred. Injury details were available in 185 reports, with the most common injury types being superficial skin injury (15.1%; 28 of 185), soft tissue injury (5.9%; 11 of 185), and musculoskeletal injury (5.4%; 10 of 185). Discharge plan outcome was determined in 141 reports, with the majority (80.9%; 114 of 141) indicating the discharge proceeded as planned. Information about staff presence/assistance was available in 206 reports, with over two-thirds (71.8%; 148 of 206) indicating that staff was not present when the fall occurred. Four discharge-related activities were identified and associated with falls: dressing, packing/gathering belongings, showering/washing up, and entering a vehicle. Conclusion: This study identifies the time frame surrounding discharge as a critical and high-risk period for falls, representing a greater threat to patient safety than previously recognized. The significantly greater proportion of serious events in the falls surrounding discharge group compared to the broader comparison group highlights the elevated patient safety risk during this transitional period. By identifying specific discharge-related activities associated with falls, this study offers actionable insights for targeted interventions. Implementing focused strategies and integrating fall prevention into discharge planning and patient education may enhance safety and reduce the risk of serious fall-related events during this vulnerable period. Plain Language Summary: Patient falls while in the hospital, or at home following a recent hospitalization, are a well-known safety concern and the focus of many quality improvement studies and interventions. However, not much attention has been given to another high-risk period for inpatient falls: the day of and in the time surrounding discharge, before leaving the hospital. Although a patient is ready to be discharged, they may still be at risk of falling. Taking a fresh perspective on patient falls, Patient Safety Authority researchers shine a light on the unique circumstances around hospital discharge to show that this time frame poses a greater threat to patient safety than ever considered before. Their data analysis suggests that inpatients may even be more at risk of serious events due to falls in this critical period than at other times during hospitalization. In this article, the authors identify discharge-related activities associated with patient falls (dressing, packing belongings, showering, and getting into a car) and fall prevention strategies, emphasizing the importance of maintaining vigilance throughout the discharge process until the patient has left the hospital.
- 18 August 2025
- Published by Patient Safety Authority in Patient Safety
- Vol. 7 (2)
Open AccessThe Overlooked Threat of Hospital Falls During the Discharge Period: A Statewide Retrospective Analysis of Patient Safety Event Reports
Background: Inpatient falls continue to be a patient safety challenge, with 35,450 falls reported to the Pennsylvania Patient Safety Reporting System (PA-PSRS) in 2024. While previous research has primarily focused on inpatient or post-discharge falls, the transitional period surrounding discharge has been understudied. Methods: We queried the PA-PSRS database for fall reports submitted between July 1, 2023, and June 30, 2024. Using a stepwise refinement process, we identified a subset of falls that occurred around the time of discharge for inclusion in the falls surrounding discharge group. We used a two-proportion z-test to compare the proportion of serious events between the discharge group and the broader comparison group. We further analyzed and coded reports from the falls surrounding discharge group to identify fall type, discharge phase, injury type, discharge plan outcome, and staff presence/assistance. Results: A total of 253 falls surrounding discharge were identified for analysis. The proportion of serious events in this group (7.5%; 19 of 253) was significantly greater than in the comparison group (2.9%; 749 of 25,701; pambulating was the most common (33.2%; 84 of 253). Over one-quarter of patients (28.5%; 72 of 253) were in the discharge complete phase when their fall occurred. Injury details were available in 185 reports, with the most common injury types being superficial skin injury (15.1%; 28 of 185), soft tissue injury (5.9%; 11 of 185), and musculoskeletal injury (5.4%; 10 of 185). Discharge plan outcome was determined in 141 reports, with the majority (80.9%; 114 of 141) indicating the discharge proceeded as planned. Information about staff presence/assistance was available in 206 reports, with over two-thirds (71.8%; 148 of 206) indicating that staff was not present when the fall occurred. Four discharge-related activities were identified and associated with falls: dressing, packing/gathering belongings, showering/washing up, and entering a vehicle. Conclusion: This study identifies the time frame surrounding discharge as a critical and high-risk period for falls, representing a greater threat to patient safety than previously recognized. The significantly greater proportion of serious events in the falls surrounding discharge group compared to the broader comparison group highlights the elevated patient safety risk during this transitional period. By identifying specific discharge-related activities associated with falls, this study offers actionable insights for targeted interventions. Implementing focused strategies and integrating fall prevention into discharge planning and patient education may enhance safety and reduce the risk of serious fall-related events during this vulnerable period. Plain Language Summary: Patient falls while in the hospital, or at home following a recent hospitalization, are a well-known safety concern and the focus of many quality improvement studies and interventions. However, not much attention has been given to another high-risk period for inpatient falls: the day of and in the time surrounding discharge, before leaving the hospital. Although a patient is ready to be discharged, they may still be at risk of falling. Taking a fresh perspective on patient falls, Patient Safety Authority researchers shine a light on the unique circumstances around hospital discharge to show that this time frame poses a greater threat to patient safety than ever considered before. Their data analysis suggests that inpatients may even be more at risk of serious events due to falls in this critical period than at other times during hospitalization. In this article, the authors identify discharge-related activities associated with patient falls (dressing, packing belongings, showering, and getting into a car) and fall prevention strategies, emphasizing the importance of maintaining vigilance throughout the discharge process until the patient has left the hospital.
- Open Access
- 6 May 2025
- Published by Patient Safety Authority in Patient Safety
- Vol. 7 (2)
Wrong Drug Events Across Pennsylvania Healthcare Facilities: A Systematic Analysis of Medication Pairs, Class Patterns, and Clinical Safety Implications
Background: Medication errors represent a significant challenge to patient safety. Wrong drug events (WDEs), which occur when a patient receives a medication different from the one intended, can cause serious patient harm. Methods: We queried the Pennsylvania Patient Safety Reporting System (PA-PSRS) database for wrong drug medication error reports submitted in calendar year 2023 to identify WDEs that reached the patient in which one medication was inadvertently ordered, dispensed, or administered in place of another medication that contained a different active ingredient. Results: We identified and analyzed 450 WDE reports from 127 different healthcare facilities. Insulin was the most frequently reported medication class, comprising 10.3% (93 of 900) of all reported medications involved in a WDE, followed by antibacterial for systemic use (n=90), electrolyte solution (n=62), and opioid (n=51). Many WDEs occurred within the same medication class, highlighting their shared stem names. Conclusion: WDEs can cause serious patient harm resulting from omission or delay of a necessary medication, administration of an unintended and/or contraindicated medication, or other deviation due to confusion between two medications. Medications belonging to the same class, as well as those sharing similar names, require heightened attention. Additional research regarding the contributing factors to WDEs could provide a more complete understanding of these events and facilitate further development of evidence-based, targeted prevention strategies. Plain Language Summary: It’s easy to mix up names, like say “sucrose” and “sucralose”—the first is commonly called sugar, and the second is an artificial sweetener better known by its brand name, Splenda. Confusing ingredients while baking is usually a harmless mistake, but if you confuse medications, for example Premarin (used to treat symptoms of menopause) and permethrin (used to treat lice), there could be a serious problem. This type of medication error is considered a wrong drug event (WDE), in which a patient receives a medication different from the one intended. WDEs can result in patient harm from missing or delaying needed medication; administering an unnecessary or contraindicated medication; or administering a medication in other incorrect ways, such as wrong route and dose. One major contributing factor to WDEs is confused drug names, involving those that are similar in how they are spoken or written—known as “look-alike, sound-alike” medications. This can occur with generic names (e.g., azithromycin, clarithromycin, and erythromycin), brand names (e.g., Solu-Cortef and Solu-Medrol), abbreviations (e.g., TPA and TNK), or any combination thereof. In this study, researchers analyzed patient safety event reports from the Pennsylvania Patient Safety Reporting System and identified the individual specific medications, pairs, and classes most frequently involved in WDEs and summarized the serious events that resulted in patient harm. Their work highlights the importance of giving close attention to medications with similar names, particularly those within the same medication class that share the same stem, such as “phrine” as in epinephrine and norepinephrine.
- 6 May 2025
- Published by Patient Safety Authority in Patient Safety
- Vol. 7 (2)
Open AccessWrong Drug Events Across Pennsylvania Healthcare Facilities: A Systematic Analysis of Medication Pairs, Class Patterns, and Clinical Safety Implications
Background: Medication errors represent a significant challenge to patient safety. Wrong drug events (WDEs), which occur when a patient receives a medication different from the one intended, can cause serious patient harm. Methods: We queried the Pennsylvania Patient Safety Reporting System (PA-PSRS) database for wrong drug medication error reports submitted in calendar year 2023 to identify WDEs that reached the patient in which one medication was inadvertently ordered, dispensed, or administered in place of another medication that contained a different active ingredient. Results: We identified and analyzed 450 WDE reports from 127 different healthcare facilities. Insulin was the most frequently reported medication class, comprising 10.3% (93 of 900) of all reported medications involved in a WDE, followed by antibacterial for systemic use (n=90), electrolyte solution (n=62), and opioid (n=51). Many WDEs occurred within the same medication class, highlighting their shared stem names. Conclusion: WDEs can cause serious patient harm resulting from omission or delay of a necessary medication, administration of an unintended and/or contraindicated medication, or other deviation due to confusion between two medications. Medications belonging to the same class, as well as those sharing similar names, require heightened attention. Additional research regarding the contributing factors to WDEs could provide a more complete understanding of these events and facilitate further development of evidence-based, targeted prevention strategies. Plain Language Summary: It’s easy to mix up names, like say “sucrose” and “sucralose”—the first is commonly called sugar, and the second is an artificial sweetener better known by its brand name, Splenda. Confusing ingredients while baking is usually a harmless mistake, but if you confuse medications, for example Premarin (used to treat symptoms of menopause) and permethrin (used to treat lice), there could be a serious problem. This type of medication error is considered a wrong drug event (WDE), in which a patient receives a medication different from the one intended. WDEs can result in patient harm from missing or delaying needed medication; administering an unnecessary or contraindicated medication; or administering a medication in other incorrect ways, such as wrong route and dose. One major contributing factor to WDEs is confused drug names, involving those that are similar in how they are spoken or written—known as “look-alike, sound-alike” medications. This can occur with generic names (e.g., azithromycin, clarithromycin, and erythromycin), brand names (e.g., Solu-Cortef and Solu-Medrol), abbreviations (e.g., TPA and TNK), or any combination thereof. In this study, researchers analyzed patient safety event reports from the Pennsylvania Patient Safety Reporting System and identified the individual specific medications, pairs, and classes most frequently involved in WDEs and summarized the serious events that resulted in patient harm. Their work highlights the importance of giving close attention to medications with similar names, particularly those within the same medication class that share the same stem, such as “phrine” as in epinephrine and norepinephrine.
- Open Access
- 21 April 2025
- Published by Patient Safety Authority in Patient Safety
- Vol. 7 (2)
Patient Safety Trends in 2024: An Analysis of 315,418 Serious Events and Incidents From the Nation’s Largest Event Reporting Database
Background: The Pennsylvania Patient Safety Reporting System (PA-PSRS) is the largest patient safety data repository of its kind in the United States and one of the largest globally, housing over 5 million reports submitted since 2004. In this article, we present data from reports submitted to PA-PSRS in 2024. Methods: We used data extracted from PA-PSRS and obtained from the Pennsylvania Health Care Cost Containment Council (PHC4). Report counts are based on the date the report was submitted, while reporting rates are calculated using the event occurrence date. Rates are expressed per 1,000 patient days for hospitals or 1,000 surgical encounters for ambulatory surgical facilities (ASFs). Results: In 2024, 315,418 reports were submitted to PA-PSRS, marking a 9.5% increase from 2023. Reports of serious events rose by 7.3%, while high harm events increased by 1.1%. Of all reports, 96.0% came from hospitals, while 4.0% originated from nonhospital facilities (ASFs, birthing centers, and abortion facilities). The vast majority (96.0%) were incidents, while the remaining 4.0% were classified as serious events. Preliminary 2024 reporting rates show 32.2 reports per 1,000 patient days for hospitals and 11.4 reports per 1,000 surgical encounters for ASFs, with both rates increasing by 1.1 points from 2023. Error Related to Procedure/Treatment/Test (P/T/T) remained the most frequently reported event type overall, accounting for 33.4% of reports from all facilities combined and 47.6% from nonhospital facilities. Among serious events, Complication of P/T/T was the most common type, making up 57.7% of serious event reports from all facilities combined and 71.4% from nonhospital facilities. Conclusion: In 2024, the total number of reports, serious event reports, and high harm event reports increased, as did the preliminary reporting rates for hospitals and ASFs. The Patient Safety Authority will continue working with Pennsylvania healthcare facilities to enhance reporting quality and promote patient safety. Plain Language Summary: In conjunction with the Patient Safety Authority’s 2024 annual report, PSA data analysts took a close look at the 315,418 incidents and serious events reported last year by hospitals, ambulatory surgical facilities (ASFs), birthing centers, and abortion facilities to the Pennsylvania Patient Safety Reporting System (PA-PSRS). The total number of reports, serious event reports, and high harm event reports increased 9.5% from 2023 to 2024, as did the preliminary reporting rates for hospitals (32.2 reports per 1,000 patient days) and ASFs (11.4 reports per 1,000 surgical encounters), with both rates increasing by 1.1 points from 2023. This comprehensive review and analysis of 2024 PA-PSRS reports provides insights into patient safety in Pennsylvania and how PSA and facilities may continue to improve it together.
- 21 April 2025
- Published by Patient Safety Authority in Patient Safety
- Vol. 7 (2)
Open AccessPatient Safety Trends in 2024: An Analysis of 315,418 Serious Events and Incidents From the Nation’s Largest Event Reporting Database
Background: The Pennsylvania Patient Safety Reporting System (PA-PSRS) is the largest patient safety data repository of its kind in the United States and one of the largest globally, housing over 5 million reports submitted since 2004. In this article, we present data from reports submitted to PA-PSRS in 2024. Methods: We used data extracted from PA-PSRS and obtained from the Pennsylvania Health Care Cost Containment Council (PHC4). Report counts are based on the date the report was submitted, while reporting rates are calculated using the event occurrence date. Rates are expressed per 1,000 patient days for hospitals or 1,000 surgical encounters for ambulatory surgical facilities (ASFs). Results: In 2024, 315,418 reports were submitted to PA-PSRS, marking a 9.5% increase from 2023. Reports of serious events rose by 7.3%, while high harm events increased by 1.1%. Of all reports, 96.0% came from hospitals, while 4.0% originated from nonhospital facilities (ASFs, birthing centers, and abortion facilities). The vast majority (96.0%) were incidents, while the remaining 4.0% were classified as serious events. Preliminary 2024 reporting rates show 32.2 reports per 1,000 patient days for hospitals and 11.4 reports per 1,000 surgical encounters for ASFs, with both rates increasing by 1.1 points from 2023. Error Related to Procedure/Treatment/Test (P/T/T) remained the most frequently reported event type overall, accounting for 33.4% of reports from all facilities combined and 47.6% from nonhospital facilities. Among serious events, Complication of P/T/T was the most common type, making up 57.7% of serious event reports from all facilities combined and 71.4% from nonhospital facilities. Conclusion: In 2024, the total number of reports, serious event reports, and high harm event reports increased, as did the preliminary reporting rates for hospitals and ASFs. The Patient Safety Authority will continue working with Pennsylvania healthcare facilities to enhance reporting quality and promote patient safety. Plain Language Summary: In conjunction with the Patient Safety Authority’s 2024 annual report, PSA data analysts took a close look at the 315,418 incidents and serious events reported last year by hospitals, ambulatory surgical facilities (ASFs), birthing centers, and abortion facilities to the Pennsylvania Patient Safety Reporting System (PA-PSRS). The total number of reports, serious event reports, and high harm event reports increased 9.5% from 2023 to 2024, as did the preliminary reporting rates for hospitals (32.2 reports per 1,000 patient days) and ASFs (11.4 reports per 1,000 surgical encounters), with both rates increasing by 1.1 points from 2023. This comprehensive review and analysis of 2024 PA-PSRS reports provides insights into patient safety in Pennsylvania and how PSA and facilities may continue to improve it together.
- Open Access
- 21 April 2025
- Published by Patient Safety Authority in Patient Safety
- Vol. 7 (2)
Long-Term Care Healthcare-Associated Infections in 2024: An Analysis of 26,501 Reports
Background: The Pennsylvania Patient Safety Reporting System (PA-PSRS) is the largest repository of patient safety data of its kind in the United States. The PA-PSRS database contains over 5 million reports, including more than 448,000 long-term care (LTC) healthcare-associated infection (HAI) reports. Methods: LTC HAI data from PA-PSRS were extracted on March 1, 2025. Infection counts were calculated based on report submission date, and rates were calculated based on infection confirmation date. Reports from LTC facilities and specific care areas were included in rate calculations if resident and device days were also entered in PA-PSRS for the corresponding month. Results: In 2024, Pennsylvania’s LTC facilities submitted 26,501 infection reports to PA-PSRS, which is a 10.6% increase over the prior year and the third consecutive annual increase. The overall infection rate was 1.08 infections per 1,000 resident days, representing a 9.1% increase from 2023. The 2024 rate also established a significant three-year upward trend since the low point of 0.77 in 2021 (R2=0.998, p=0.0011). All six regions of the state had an increase in infection rate. The overall infection rate increased due to rising rates across all infection types, except for device-related bloodstream infections. Conclusion: In 2024, there was a rise in both the number of infection reports submitted to PA-PSRS and the overall infection rate. This third consecutive annual increase may be associated with enhanced surveillance and reporting in Pennsylvania’s LTC facilities stemming from the Patient Safety Authority’s intensive outreach and educational efforts. Plain Language Summary: In conjunction with the Patient Safety Authority’s 2024 annual report, PSA data analysts took a close look at the 26,501 healthcare-associated infections (HAIs) reported last year by long-term care (LTC) facilities (e.g., nursing homes) to the Pennsylvania Patient Safety Reporting System (PA-PSRS), one of the largest patient safety data repositories of its kind in the world. The total number of infection reports was a 10.6% increase from 2023 to 2024, the third consecutive annual increase, which may be associated with enhanced surveillance and reporting in Pennsylvania’s LTC facilities stemming from PSA’s intensive outreach and educational efforts.
- 21 April 2025
- Published by Patient Safety Authority in Patient Safety
- Vol. 7 (2)
Open AccessLong-Term Care Healthcare-Associated Infections in 2024: An Analysis of 26,501 Reports
Background: The Pennsylvania Patient Safety Reporting System (PA-PSRS) is the largest repository of patient safety data of its kind in the United States. The PA-PSRS database contains over 5 million reports, including more than 448,000 long-term care (LTC) healthcare-associated infection (HAI) reports. Methods: LTC HAI data from PA-PSRS were extracted on March 1, 2025. Infection counts were calculated based on report submission date, and rates were calculated based on infection confirmation date. Reports from LTC facilities and specific care areas were included in rate calculations if resident and device days were also entered in PA-PSRS for the corresponding month. Results: In 2024, Pennsylvania’s LTC facilities submitted 26,501 infection reports to PA-PSRS, which is a 10.6% increase over the prior year and the third consecutive annual increase. The overall infection rate was 1.08 infections per 1,000 resident days, representing a 9.1% increase from 2023. The 2024 rate also established a significant three-year upward trend since the low point of 0.77 in 2021 (R2=0.998, p=0.0011). All six regions of the state had an increase in infection rate. The overall infection rate increased due to rising rates across all infection types, except for device-related bloodstream infections. Conclusion: In 2024, there was a rise in both the number of infection reports submitted to PA-PSRS and the overall infection rate. This third consecutive annual increase may be associated with enhanced surveillance and reporting in Pennsylvania’s LTC facilities stemming from the Patient Safety Authority’s intensive outreach and educational efforts. Plain Language Summary: In conjunction with the Patient Safety Authority’s 2024 annual report, PSA data analysts took a close look at the 26,501 healthcare-associated infections (HAIs) reported last year by long-term care (LTC) facilities (e.g., nursing homes) to the Pennsylvania Patient Safety Reporting System (PA-PSRS), one of the largest patient safety data repositories of its kind in the world. The total number of infection reports was a 10.6% increase from 2023 to 2024, the third consecutive annual increase, which may be associated with enhanced surveillance and reporting in Pennsylvania’s LTC facilities stemming from PSA’s intensive outreach and educational efforts.